劢柏资本
  • Home
  • About
  • The Case
  • News
  • Contact Us
中文
  • 2025-12-31
    China National Medicines (Genertec, 600056···
    On the evening of December 30, 2025, China National Medicines (600056) announced that the company had entered into a Share Purchase Agreement regarding Shanghai Zezheng Pharmaceutical Technology Co., Ltd. with 13 counterparties—He Dunwei, Wu Dong, Wankang Healthcare Co., Ltd., Zhang Wei, Jiaxing Renhe Jiarui Equity Investment Partnership (Limited Partnership), Yang Zhenyu, Xinyu Renhe Ruiyun Investment Partnership (Limited Partnership), Tang Xudong, Xinyu Renhe Chunrun Investment Partnership (Limited Partnership), Yantai Guoxin Zezheng Equity Investment Partnership (Limited Partnership), Wang Qinghan, Changzhou Binfu Yinaiersheng Venture Capital Partnership (Limited Partnership) and Zhang Qing—to acquire, for a cash consideration of RMB 525 million, a 70% equity interest in Shanghai Zezheng Pharmaceutical Technology Co., Ltd. (hereinafter “HQ Pharma”) held in aggregate by the counterparties. MedBio Capital acted as exclusive financial advisor to the sellers.
  • 2025-07-18
    Robo Medical Completes a New Financing Rou···
    Shenzhen Robo Medical Technology Co., Ltd. (hereinafter “Robo Medical”) has recently completed a strategic financing round of tens of millions of yuan. The round was led by Yuanchang Fund under Fenglei Capital, with existing shareholder Taikun Fund participating as a follow-on investor, and MedBio Capital continued to serve as exclusive financial advisor.
  • 2025-03-18
    Puruishunxiang Completes Series A Financin···
    Recently, Puruishunxiang, a leading domestic supplier of minimally invasive surgical instrument products, successfully obtained a Series A investment of tens of millions of yuan from Yizhuang Guotou, and MedBio Capital served as the financial advisor for this financing transaction. The company has already launched a new financing round, and MedBio Capital continues to provide its services.
  • 2022-12-02
    极智医疗完成数千万A轮融资,劢柏资本担任财务···
    近日,杭州极智医疗科技有限公司(以下简称“极智医疗”)母公司北京力泰克科技有限公司完成数千万A轮融资。本轮融资由中国新兴资产和乾道集团共同投资,劢柏资本担任财务顾问。融资资金将围绕公司的愿景和使命,为行业提供Available、Affordable的数字化康复机器人及健身产品,推动公司力矩电机产品的规模化量产及营销布局
  • 2022-10-13
    桦冠生物完成亿元B轮融资,劢柏资本担任财务顾···
    2022年8月,北京桦冠生物技术有限公司(以下简称:桦冠生物)宣布完成亿元以上B轮融资,由北京中关村科学城公司领投,荷塘创投、重庆桦泽锦灵与盛美嘉乐跟投,劢柏资本担任财务顾问。同时,劢柏资本作为独家财务顾问协助融资桦冠生物进行后续的融资及产业合作。桦冠生物成立于2018年,以引领行业发展方向,解决产业升级痛点
Start Prev 123 Next End
  • 粤ICP备2021058455号-1
  • Copyright © 2015-2026 All Rights Reserved.
Add
  • Room 2012, Zhongxiu Building, Building 1, No. 10 Courtyard of Guanghua Road, Chaoyang District, Beijing
  • Room 639, block C, Bohui Plaza, No. 768, Zhongshan South 1st Road, Huangpu District, Shanghai
Email
  • Investor Relations ir@medbiocapital.com
  • BP Channel bp@medbiocapital.com
  • Recruit hr@medbiocapital.com
  • Media pr@medbiocapital.com
Pay attention to us